Mumbai (Maharashtra) [India], September 26 (ANI): Pharma company Cipla has launch its drone-based deliveries of its critical medicines (cardiac, respiratory, and other essential chronic therapies) for hospitals and pharmacies in Himachal Pradesh in partnership with Sky Air Mobility.

The use of drones will support delivery of Cipla’s medicines to chemists and clinics in remote areas, while minimizing risks such as delays, it said in a release on Tuesday.

Also Read | Indian Army Jawan Arrested by Kerala Police for Faking Assault by 'PFI' Activists (Watch Video).

Cipla claimed it is the first among large Indian pharma companies to adopt drone-based deliveries to facilitate expedited supply to stockists in remote areas.

In its inaugural phase, the company said it has successfully completed several drone deliveries in Himachal Pradesh covering approximately 50 kilometres distance in under 25 minutes.

Also Read | Xiaomi 13T, Xiaomi 13T Pro With Leica-Powered Camera Launched in Berlin; Check Design, Specifications and Other Details Here.

“Driven by our purpose of ‘Caring for Life’, we are leveraging technology to make healthcare more accessible and extend our circle of care to all our key stakeholders. As we accelerate our digital agenda across all functions, implementing drone-powered distribution enhances our supply chain resilience, strengthens connects with channel partners, helps us stay future ready and maintain reliable, prompt delivery of our trusted high-quality drugs to stockists and patients in the region,” said Cipla’s Global Supply Chain Head, Swapn Malpani.

Going ahead, Cipla aims to scale the service and expand coverage to inaccessible and hilly terrains in Uttarakhand and northeast region. (ANI)

(The above story is verified and authored by ANI staff, ANI is South Asia's leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)